Pinnacle Associates
CLB icon

Pinnacle Associates’s Core Laboratories CLB Stock Holding History

Pinnacle Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$810K Buy
+83,519
New +$967K 0.01% 574
2022
Q3 		– Sell
-10,805
Closed -$214K – 743
2022
Q2 		$214K Sell
10,805
-5,220
-33% -$139K ﹤0.01% 694
2022
Q1 		$507K Buy
+16,025
New +$449K 0.01% 559

Other funds holding CLB

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Moors & Cabot
Moors & Cabot Boston, Massachusetts $2.65B AUM 29.91% 1-Year Est. Return

Pinnacle Associates's CLB Position: Q3 2026 in Review

Pinnacle Associates opened a new position in Core Laboratories (CLB) in Q3 2026: 83,519 shares worth $810K. The stake represents 0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: Pinnacle Associates previously reported a position in CLB as recently as Q2 2022.

Pinnacle Associates first reported a position in CLB in Q1 2022 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Pinnacle Associates held 83,519 shares of Core Laboratories worth $810K as of Q3 2026.
  • Core Laboratories was a new Pinnacle Associates position in Q3 2026.
  • Core Laboratories made up 0.01% of Pinnacle Associates's portfolio in Q3 2026, its #574 holding.
  • Pinnacle Associates first reported a position in Core Laboratories in Q1 2022 and has held it in 3 quarters since.
  • 62 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.